Abstract

Get full access to this article
View all access options for this article.
References
1.
Ellis
L.
The need to treat the ailing U.S. pharmaceutical pricing system, www.hsph.harvard.edu/ecpe/united-states-pharmaceutical-pricing/ (accessed 21 June 2021 ).
2.
Blumberg
Y.
Here’s why many prescription drugs in the US cost so much – and it’s not innovation or improvement, www.cnbc.com/2019/01/10/why-prescription-drugs-in-the-us-cost-so-much.html (accessed 21 June 2021 ).
3.World Trade Organization. Obligations and exceptions , www.wto.org/english/tratop_e/trips_e/factsheet_pharm02_e.htm (2006, 21 June 2021 ).
4.
World Trade Organization. Obligations and exceptions, https://www.wto.org/english/res_e/publications_e/legal_texts_e.htm (2006, 6 July 2021).
5.World Trade Organization. Declaration on the TRIPS agreement and public health , www.wto.org/english/thewto_e/minist_e/min01_e/mindecl_trips_e.htm (2001, accessed 21 June 2021 ).
6.
Wibulpolprasert
S
Chokevivat
V
Oh
C
, et al .
Government use licenses in Thailand: the power of evidence, civil movement and political leadership. Global Health 2011 ;
7 : 32 .
7.
Steinbrook
R.
Thailand and the compulsory licensing of efavirenz. N Engl J Med 2007 ;
356 : 544 –546 .
8.
Estavillo
M.
India grants first compulsory licence, for Bayer cancer drug, www.ip-watch.org/2012/03/12/india-grants-first-compulsory-licence-for-bayer-cancer-drug/ (2012, accessed 21 June 2021 ).
9.ACSH Staff . Government is the big reason EpiPen and other generics are so expensive, www.acsh.org/news/2018/06/23/government-big-reason-epipen-and-other-generics-are-so-expensive-13114 (2018, accessed 21 June 2021 ).
